rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1997-11-20
|
pubmed:abstractText |
We here report the case of a patient who had undergone total thyroid ablation for Graves' disease. After the beginning of oral therapy with 1-thyroxine, she developed a left external ophthalmoparesis that remitted with the discontinuation of the drug and recurred whenever the replacement therapy (1-thyroxine or tri-iodothyronine) was reintroduced.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0392-0461
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
215-6
|
pubmed:dateRevised |
2008-9-16
|
pubmed:meshHeading |
|
pubmed:year |
1997
|
pubmed:articleTitle |
Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.
|
pubmed:affiliation |
Divisione di Neurologia, Ospedale Civile di Belluno, Italy.
|
pubmed:publicationType |
Journal Article,
Case Reports
|